Karolinska Development: Where we stand after resolved on short-term finances

Research Note

2020-01-21

09:13

In November, after months of negotiations, 94.2 percent of the convertible holders committed to converting or repurchase. Since then, the company has repaid the remaining part of the convertible loan and secured short-term finances via a loan of SEK 70 million from Sino Biopharma (largest shareholder in KD). This is where we stand regarding our coverage.

AH

Anders Hedlund

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.